US 11352417
Method of treating an allergy with allergen-specific monoclonal antibodies
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11352417 (Method of treating an allergy with allergen-specific monoclonal antibodies) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/54, A61K2039/545